Lucigen Corp. Revenue and Competitors
Estimated Revenue & Valuation
- Lucigen Corp.'s estimated annual revenue is currently $4.3M per year.
- Lucigen Corp.'s estimated revenue per employee is $155,000
Employee Data
- Lucigen Corp. has 28 Employees.
- Lucigen Corp. grew their employee count by -12% last year.
Lucigen Corp.'s People
Name | Title | Email/Phone |
---|---|---|
1 | R&D Scientist II | Reveal Email/Phone |
2 | Laboratory Technician I | Reveal Email/Phone |
Lucigen Corp. Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Lucigen Corp.?
Lucigen is working to improve people’s lives by providing quality biomedical products and services used across the spectrum from basic research to molecular diagnostics. We manufacture and sell over 325 biomedical research products to life-science and healthcare professionals worldwide. Lucigen leverages its expertise in enzyme evolution and core competencies that support a variety of applications such as synthetic biology, next gen sequencing, and human diagnostics. Lucigen’s acquisition of Epicentre products expanded our portfolio offering into array-based analysis, in vitro transcription, nucleic-acid extraction purification, and transposon mutagenesis. As an ISO 13485-certified company, we proudly offer catalog and custom solutions to meet researchers’ expanding needs, including OEM partnerships.
keywords:N/AN/A
Total Funding
28
Number of Employees
$4.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.8M | 28 | 0% | N/A |
#2 | $4.8M | 28 | -32% | N/A |
#3 | $3.7M | 29 | 4% | N/A |
#4 | $3M | 29 | 12% | N/A |
#5 | $4.9M | 30 | -17% | N/A |